This weekend brings a Veterans Day ceremony, an opportunity to explore the night sky, a basketball game, Laser Foo Fighters, “The Importance of Being Earnest,” an end-of-season celebration with the E-Center, “The Drowsy Chaperone” and more.
It may be tempting to skim through a lease, but you could miss important information or an opportunity to negotiate more favorable terms. With many students preparing to sign a lease for next year’s housing, here are some things to know.
A CU Boulder bridge program is designed to help student veterans transition to university life through acclimation to academics and social opportunities on campus.
When CU Boulder’s student population nearly doubled during the end of World War II, the university set out to house more than 4,600 vets—many with spouses and children—who received GI Bill benefits.
You're invited to attend a livestream discussion with the Polaris Dawn crew: Sarah Gillis—a CU Boulder alumna—Jared Isaacman, Anna Menon and Scott Poteet. The crew will spend up to five days in orbit conducting research on human health and laser-based communications technology. The launch will include experiments from Professors Allie Anderson and Torin Clark.
Get creative with the CU Art Museum on the second Saturday of each month. Organizers will put together a different art-themed program each time, and the community is invited to drop in. Join, enjoy and even pick up a new skill—next session Dec. 10.
At the global climate summit next month, teachers and aspiring teachers will be in the audience and working with an educator's guide created at CU Boulder to help their students understand how climate change is impacting people and communities and how they can help. Participating teachers may apply for graduate credit and a stipend—deadline Nov. 16.
Vitro3D, a startup founded by CU Boulder doctoral students, just closed its first investment round of $1.3 million. The venture involves novel, high-speed volumetric 3D printing technology with potential applications in industries such as dental, medical and drug development.